Michael A. Davies MD, PhD

Michael A. Davies, MD, PhD, is a Professor and Chair in the Department of Melanoma Medical Oncology at the University of Texas MD Anderson Cancer Center in Houston, Texas. He has joint appointments in the Department of Systems Biology and the Department of Translational Molecular Pathology.

Dr. Davies obtained his medical degree from the University of Texas Health Science Center in Houston, Texas. He then completed a residency in Internal Medicine at Massachusetts General Hospital in Boston, Massachusetts, followed by a fellowship in Medical Oncology at the University of Texas MD Anderson Cancer Center in Houston.

Dr. Davies is an expert in the management of advanced melanoma, including treatment with immunotherapy, targeted therapy, and chemotherapy, as well in developing integrated multidisciplinary care plans for patients. In his research, Dr. Davies has identified clinical associations of oncogenic mutations and signaling pathways; novel strategies to overcome resistance to targeted and immune therapies; and new predictors and therapeutic approaches for central nervous system (CNS) metastases from melanoma. He has led multiple clinical trials focusing on advanced melanoma, and leads a translational laboratory research program. Dr. Davies is also the President and on the Executive Committee of the Society for Melanoma Research and is the Co-Leader of the MD Anderson Melanoma Moon Shot Program.